ClinicalTrials.govpublic full text
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
multiple myeloma progression, multiple myeloma, teclistamab, pomalidomid, t-cell-engaging bispecific antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 889295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.